Scotland hospital vaccine Scotland

Study: Delta variant can reduce Pfizer, Astrazeneca COVID-19 vaccine effectiveness

Reading now: 387
www.fox29.com

The Lancet on Monday, researchers observed patients both vaccinated and unvaccinated who tested positive for COVID-19 between April 1 to June 6, 2021 in Scotland, where the Delta variant has become dominant. RELATED: COVID Delta variant prevalent, vaccinations stall Pfizer’s vaccine "offered very good protection: 92% (95% CI 90–93) S gene-negative, 79% (75–82) S gene-positive.

Protection associated with ChAdOx1 nCoV-19 (Oxford–AstraZeneca vaccine) was, however, substantial but reduced: 73% (95% CI 66–78) for S gene-negative cases versus 60% (53–66) for those S gene-positive," according to The Lancet.

Authors of The Lancet study noted further research needs to be done for more accurate percentage estimates on both vaccines’.

Read more on fox29.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA